Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Lundbeck raises financial guidance for 2024

Valby, Denmark, August 20, 2024 - H. Lundbeck A/S (Lundbeck) announced revenue and adjusted EBITDA growth at constant exchange rates (CER) for the first six months of 2024 and that the full year revenue and adjusted EBITDA outlook at CER have been raised. In the second quarter of 2024, Lundbeck’s revenue increased by 13% and adjusted EBITDA increased by 14% both at CER. Key figures Growth (CER) H1 2024 Q2 2024Revenue 10% 13%EBITDA 9% 17%Adjusted EBITDA 5% 14% The sales outlook for 2024 is updated, primarily reflecting

Nightingale Health attains UKCA marking for its blood analysis technology to bring its technology to healthcare use in the United Kingdom

Nightingale Health Plc Press release 20 August 2024 at 9:45 a.m. (EEST)   Nightingale Health Plc (“Nightingale Health”), a pioneer in disease risk detection and preventative health, has attained UKCA (UK Conformity Assessed) marking under the UK Medical Devices Regulations. Nightingale Health has already been working for years with many leading universities in the UK and the technology is being used by many landmark health initiatives, such as the UK Biobank, to profile their entire sample collections.  To expand its activities in the UK, Nightingale Health has established

Axfood enters into agreement with Linas Matkasse and closes down Middagsfrid

Due to weak market development for pre-planned subscribed meal kits, Axfood has made the decision to close downs its meal kit company Middagsfrid as of the last day in September, and make use of the value Middagsfrid has created in other ways. In conjunction with closing down the operations, an agreement is entered into with Linas Matkasse around cooperation to continue to offer the customers of Middagsfrid meal kits to their homes.Middagsfrid was established in 2007 and was first to offer home delivery of pre-planned subscribed meal kits. Axfood acquired Middagsfrid in 2017 to further

Interim report January – June 2024

NET ASSET VALUE AND THE LATOUR SHARE · The net asset value at the end of the period was SEK 198 per share compared with SEK 198 per share at the start of the year, which is an increase of 1.8 per cent adjusted for dividends. The benchmark index (SIXRX) rose 10.6 per cent. The net asset value at 19 August was SEK 204 per share.[1] · The total return on the Latour share was 10.7 per cent measured against the SIXRX, which increased 10.6 per cent. INDUSTRIAL OPERATIONS The second quarter · The industrial operations’ order intake rose 7 per cent to SEK 6,570 m (6,128 m), a 5

Nordea Bank Abp flagging notification: Norges Bank’s shareholding decreases below threshold of five percent

Nordea Bank AbpStock exchange release – Major shareholder announcements20 August 2024 at 9.30 EET Norges Bank’s (The Central Bank of Norway) shareholding of Nordea Bank Abp’s shares and voting rights has decreased below the threshold of five percent, according to a notification Nordea received on 19 August 2024 under Chapter 9, Section 10 of the Securities Markets Act (SMA). The threshold was crossed on 16 August 2024. The total number of shares and voting rights in Nordea Bank Abp is 3,505,587,395. The total position of Norges Bank according to the notification: +-----------

Katalysen Ventures publishes report for the Second Quarter 2024

Katalysen Ventures AB (publ) hereby publishes the report for the Second Quarter 2024. The full report is available immediately as an attached document, and on the company's website. Below is a summary of the report.KPIs: · Number of ventures in portfolio at end of period: 26 (26) · Estimated portfolio market value at end of period: 147 MSEK (160 MSEK) · Cash resources in bank at end of period: 3.6 MSEK (1.2 MSEK) General Financial KPIs: Key Figures (Group*, TSEK) Q2 2024 Q2 2023 2023-01-01 2023-12-31Net sales

Nightingale Health receives additional regulatory approval for healthcare use from Health Sciences Authority in Singapore

Nightingale Health Plc Press release 20 August 2024 at 9:15 a.m. (EEST)   Nightingale Health Plc (“Nightingale Health”), a pioneer in disease risk detection and preventative health has received additional regulatory approval from Singapore’s Health Sciences Authority (HSA), the national body that regulates medical devices, therapeutics, and other healthcare products. Nightingale Health announced earlier this year the first approval that covered the analysis of eight common clinically used biomarkers: total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides,

Notice of Special General Meeting

Hamilton, Bermuda, August 20, 2024 – Paratus Energy Services Ltd. (the "Company") announces that a Special General Meeting (“SGM”) will be held on September 5, 2024. As announced on 16 August 2024, the record date for voting at the SGM is set to August 16, 2024. A copy of the Notice of the SGM and associated information is attached to this press release. This information is subject to the disclosure requirements according to Section 5-12 of the Norwegian Securities Trading Act. For further information, please contact:Robert Jensen, CEORobert.Jensen@paratus-energy.com+47 958 26

Half-Yearly Report January - June 2024

A stable quarter despite subdued market conditions April – June 2024 · Net sales totaled SEK 29,470 (29,463) thousand, with a growth rate of 0.03%. Adjusted for currency effects, the decrease is -1%.  · Operating profit before depreciation and amortization (EBITDA) totaled SEK 5,272 (7,687) thousand. · Operating profit (EBIT) totaled SEK 2,517 (5,981) thousand. · Profit for the period totaled SEK 1,790 (15,219) thousand.  · Earnings per share totaled SEK 0.03 (0.23).  · Comprehensive income for the period totaled SEK 2,467 (16,843) thousand.  · Cash flow from

Repurchases of shares during week 33

Between 12 August and 16 August 2024 Attendo AB (LEI code 549300KEJDL2FNITUW65) (“Attendo”) has repurchased in total 120,329 own shares (ISIN: SE0007666110) as part of the repurchase program initiated by the Board.The repurchases form part of the repurchase program of a maximum of 16,138,659 own shares for a total maximum amount of SEK 150,000,000 that Attendo announced on 19 July 2024. The repurchase program, which runs between 22 July 2024 and 24 October 2024, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated Regulation (EU)

Finnish PropTech Startup Make a BIM Secures Funding to Accelerate Digitisation of Aging Building Stock

Helsinki, Finland – August 20, 2024 – Finnish PropTech startup Make a BIM has successfully raised pre-seed funding to scale its operations and further develop its automation technology. The funding round was led by Kiilto Ventures , with additional investments from Innovestor and angels from the Finnish Business Angels Network (FiBAN), including Kim Väisänen, Esa Kinnunen, and Teemu Jokinen.Addressing Europe’s urgent building challenge  The European Union faces a significant challenge: 97% of its buildings require upgrades to meet the goal of a decarbonized

Notice of Half-Year Financial Results

Faron Pharmaceuticals Ltd. (“Faron” or the “Company”)   Faron Pharmaceuticals Notice of Half-Year Financial Results   Company Announcement, 20 August 2024   TURKU, Finland – Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company pursuing a CLEVER approach to reprogramming myeloid cells to activate anti-tumor immunity in hematological and solid tumor microenvironments, will report its unaudited half-year financial results for the six months ended June 30, 2024, on Tuesday, 27 August 2024.   A live hybrid briefing

New Electrolux Group study shows short wash and low temperature key to reducing environmental footprint of clothes

Seven-year research program proves clothes including jeans and T-shirts can last more than 50% longer [1] with gentler wash conditions.New research, published today in the fourth edition of The Truth About Laundry report , proves that choosing lower temperatures and shorter cycles, can lengthen the lifespan of clothes by more than 50%. Conducted by Electrolux Group, a leading home appliance company in sustainability, the study is part of a seven-year,

Interim Report for 2nd Quarter 2024

Revenues increased 7.92% and EBIT increased 117.99%Key Facts for the 2[nd] Quarter 2024 (1[st] April 2024 – 30[th] June 2024) Revenues increased 7.92% and EBIT increased 117.99% All figures are compared to the same quarter last year if not explicitly stated otherwise. ·Revenues increased by 7.92% to €10,207,914 (€9,458,630). ·EBIT increased by 117.99% to €1,474,691 (€676,489). ·EBIT margin of 14.45% (7.15%). ·Net profit increased by 202.22% to €687,154 (€227,366). ·Earnings per share of €0.0092 (€0.0030). ·PremierGaming Ltd, the Group’s B2C

Erik Selin acquires additional shares in Checkin.com

Finance profile Erik Selin has expanded his ownership in Checkin.com Group (STO:CHECK). Through his company ES Aktiehandel AB, Selin and his representative on Checkin.com's board, Jonas Strömberg, has acquired a total of 27,000 shares on August 16 for a purchase sum of 610,200 SEK. The shares were purchased from Checkin.com's CEO, Christian Karlsson, to finance the stock option program through which Karlsson increased his ownership in the company from 15,000 to 307,984 shares."The sale of these shares is part of my financing for a stock option program in which I have made a net investment

Implantica announces RefluxStop™ pivotal 4-year study results published in the prestigious journal Surgical Endoscopy

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces excellent long-term safety and clinical 4-year outcomes with the RefluxStop device (in the prospective multi-center CE study), which have recently been published in the prestigious journal, Surgical Endoscopy, an official journal of SAGES (American Gastrointestinal and Endoscopic Surgeons) and EAES (European Association For Endoscopic Surgery), entitled “Treating acid reflux without compressing the food passageway”.Results from the study confirm that 4-year outcomes mirror

Stayble Therapeutics publishes half-year report for 2024

Stayble Therapeutics AB (“Stayble” or the “Company”) hereby publishes its half-year report for 2024. The report is available as an attached document and on the Company’s website: https://staybletherapeutics.com/investor-relations/financial-reports/. Below is a summary of the report.Summary   Highlights during the second quarter (April – June 2024) · In April, it was announced that the Company's scientific abstract regarding the treatment concept for herniated discs has been accepted for a poster presentation at the International Society for the Study of the Lumbar Spine (ISSLS)

Neste expands chemical recycling logistics infrastructure at its refinery in Porvoo, Finland

Neste Corporation, News, 20 August 2024 Photo: Installation of new unloading arm for liquefied recycled raw materials at Neste Porvoo refinery harbor, Finland. Source: Neste Neste is expanding its logistics infrastructure for liquefied recycled raw materials at its refinery in Porvoo, Finland, including materials such as liquefied waste plastic and liquefied rubber tires. This lays the foundation to handling larger amounts of liquefied raw materials to support Neste’s strategic aims to advance chemical recycling and transform the Porvoo refinery into a renewable and circular

Transaction in Own Shares

    20 August 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |19/08/2024|+------------------------------------------------------------

STENOCARE updates guidance for 2024

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENO This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The information was provided by the contact person below for publication on August 20, 2024. STENOCARE A/S (“Stenocare” or the “Company”) is updating the guidance from November 06, 2023 based on actual market performance from Q1 and Q2 2024 and the forecast for Q3 and Q4 2024. The guidance of gross sales of 12-18 mDKK is now expected to be 6-8 mDKK for 2024, which is a growth of +7% compared

Changes in Anora Group’s Executive Management Team: The Head of Anora’s Industrial segment to change

Anora Group Plc   Stock exchange release   20 August 2024 at 8.35 a.m. EEST Changes in Anora Group’s Executive Management Team: The Head of Anora’s Industrial segment to change Anora Group’s Senior Vice President, Industrial, Risto Gaggl steps down from his position. He will continue in his current role with Anora until the end of 2024. Anora has appointed Hannu Vähämurto as his successor as of 1 January 2025. Hannu Vähämurto has been with Anora and its predecessor (Altia Oyj) since 2011 in various roles, most recently as Director, Industrial Products since September 2023. Prior to

There are no items matching the current filter
There are no more items matching the current filter
Back to top